From CAR-T Cells to Cancer Organoids: The Technologies Set to Transform Clinical Oncology
An editorial from Clinical Cancer Bulletin maps the converging technologies — TCR-T cells, cancer organoids, multi-specific antibody-drug conjugates, nanotechnology, and ...
